El‐Shahat A. Toson

605 total citations
34 papers, 489 citations indexed

About

El‐Shahat A. Toson is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, El‐Shahat A. Toson has authored 34 papers receiving a total of 489 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 7 papers in Molecular Biology. Recurrent topics in El‐Shahat A. Toson's work include Liver Disease Diagnosis and Treatment (8 papers), Hepatitis C virus research (6 papers) and Hepatitis B Virus Studies (4 papers). El‐Shahat A. Toson is often cited by papers focused on Liver Disease Diagnosis and Treatment (8 papers), Hepatitis C virus research (6 papers) and Hepatitis B Virus Studies (4 papers). El‐Shahat A. Toson collaborates with scholars based in Egypt, France and United States. El‐Shahat A. Toson's co-authors include Kamel R. Shoueir, A.A. El-Bindary, Hind Abdullah Aljohani, Gamal Shiha, Hatem A. El‐mezayen, Mohamed M. Abdel-Aziz, Entsar A. Saad, Mohamed Abou-Dobara, Abdelfattah M. Attallah and Mohamed M. Omran and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Hepatology.

In The Last Decade

El‐Shahat A. Toson

31 papers receiving 472 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
El‐Shahat A. Toson Egypt 13 93 83 79 78 74 34 489
Hany Elsawy Egypt 16 49 0.5× 117 1.4× 191 2.4× 194 2.5× 147 2.0× 48 877
Yaqi Zhang China 12 56 0.6× 75 0.9× 31 0.4× 121 1.6× 46 0.6× 33 494
Hualei Chen China 16 41 0.4× 111 1.3× 165 2.1× 65 0.8× 66 0.9× 51 757
Mahmoud M. A. Elsayed Egypt 14 75 0.8× 119 1.4× 111 1.4× 119 1.5× 61 0.8× 29 577
Ming Yuan China 17 96 1.0× 239 2.9× 78 1.0× 189 2.4× 32 0.4× 38 763
Mingmei Zhong China 15 60 0.6× 267 3.2× 149 1.9× 69 0.9× 14 0.2× 30 658
Bohong Guo China 14 92 1.0× 71 0.9× 147 1.9× 164 2.1× 154 2.1× 34 522
Somesh Banerjee India 13 71 0.8× 62 0.7× 102 1.3× 120 1.5× 67 0.9× 29 483
Suyavaran Arumugam India 20 131 1.4× 302 3.6× 96 1.2× 312 4.0× 65 0.9× 25 968
Subastri Ariraman India 13 70 0.8× 118 1.4× 37 0.5× 151 1.9× 61 0.8× 21 459

Countries citing papers authored by El‐Shahat A. Toson

Since Specialization
Citations

This map shows the geographic impact of El‐Shahat A. Toson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by El‐Shahat A. Toson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites El‐Shahat A. Toson more than expected).

Fields of papers citing papers by El‐Shahat A. Toson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by El‐Shahat A. Toson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by El‐Shahat A. Toson. The network helps show where El‐Shahat A. Toson may publish in the future.

Co-authorship network of co-authors of El‐Shahat A. Toson

This figure shows the co-authorship network connecting the top 25 collaborators of El‐Shahat A. Toson. A scholar is included among the top collaborators of El‐Shahat A. Toson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with El‐Shahat A. Toson. El‐Shahat A. Toson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Toson, El‐Shahat A., et al.. (2025). In vitro antitumor effects of methanolic extracts of three Ganoderema mushrooms. Scientific Reports. 15(1). 2274–2274. 2 indexed citations
2.
Toson, El‐Shahat A., et al.. (2024). Smart chitosan nanogel for targeted doxorubicin delivery, ensuring precise release, and minimizing side effects in Ehrlich ascites carcinoma-bearing mice. International Journal of Biological Macromolecules. 267(Pt 1). 131390–131390. 23 indexed citations
3.
Elsayed, Shadia A., et al.. (2023). Experimental and computational studies of silver(I) dibenzoylmethane-based complexes, interaction with DNA/RNA/BSA biomolecules, and in vitro cytotoxic activity. Journal of Inorganic Biochemistry. 241. 112132–112132. 15 indexed citations
4.
Shoueir, Kamel R., et al.. (2022). Controlled synthesis of in-situ gold nanoparticles onto chitosan functionalized PLGA nanoparticles for oral insulin delivery. International Journal of Biological Macromolecules. 209(Pt B). 2188–2196. 49 indexed citations
5.
Shoueir, Kamel R., et al.. (2021). Hepatoprotective activity and free radical scavenging against induction of CCl4 in an experimental model using dendronaphthya crude extract loaded chitosan nanocarrier. Journal of Drug Delivery Science and Technology. 66. 102906–102906. 6 indexed citations
6.
Toson, El‐Shahat A., et al.. (2021). Occupational exposure to gasoline in gasoline station male attendants promotes M1 polarization in macrophages. Environmental Science and Pollution Research. 29(5). 6399–6413. 5 indexed citations
7.
8.
Toson, El‐Shahat A., et al.. (2019). Diagnostic performance of myeloperoxidase in early identification of acute myocardial infarction among patients admitted with coronary heart disease. Journal of Chemical Biological and Physical Sciences. 9(4). 2 indexed citations
9.
Toson, El‐Shahat A., et al.. (2017). Fibrogenic/Angiogenic Linker for Non-Invasive Assessment of Hepatic Fibrosis Staging in Chronic Hepatitis C Among Egyptian Patients. Annals of Hepatology. 16(6). 862–873. 2 indexed citations
10.
Saad, Entsar A., et al.. (2015). CLOVE OR GREEN TEA ADMINISTRATION ANTAGONIZES KHAT HEPATOTOXICITY IN RATS. International Journal of Pharmacy and Pharmaceutical Sciences. 7(6). 72–76. 13 indexed citations
11.
Shoair, A.F., El‐Shahat A. Toson, & Hatem A. El‐mezayen. (2015). Synthesis, spectral characterization and anticancer studies of three novel ruthenium(III) 2,2′‐bipyridine complexes. Applied Organometallic Chemistry. 29(6). 412–418. 5 indexed citations
12.
Abou-Dobara, Mohamed, et al.. (2014). Optimization of exopolysaccharides production by Bacillus subtilis. 3(1). 11–21. 3 indexed citations
13.
El‐mezayen, Hatem A., et al.. (2012). Development of a novel metastatic breast cancer score based on hyaluronic acid metabolism. Medical Oncology. 30(1). 404–404. 6 indexed citations
14.
15.
El‐mezayen, Hatem A., El‐Shahat A. Toson, & Gamal Shiha. (2012). Role of hyaluronic acid, its degrading enzymes, degradation products, and ferritin in the assessment of fibrosis stage in Egyptian patients with chronic hepatitis C. European Journal of Gastroenterology & Hepatology. 25(1). 69–76. 12 indexed citations
16.
Attallah, Abdelfattah M., El‐Shahat A. Toson, Gamal Shiha, et al.. (2007). Evaluation of Serum Procollagen Aminoterminal Propeptide III, Laminin, and Hydroxyproline as Predictors of Severe Fibrosis in Patients with Chronic Hepatitis C. Journal of Immunoassay and Immunochemistry. 28(3). 199–211. 23 indexed citations
17.
Abdel-Aziz, Mohamed M., et al.. (2006). Immune Response on Mice Infected with Schistosoma mansoni and Treated with Myrrh. Journal of Medical Sciences(Faisalabad). 6(5). 858–861. 8 indexed citations
18.
Attallah, Abdelfattah M., et al.. (2006). Detection of a Helicobacter pylori Antigen in Cerebrospinal Fluid of Patients with Meningitis. Journal of Immunoassay and Immunochemistry. 28(1). 25–33. 5 indexed citations
19.
20.
Shiha, Gamal, et al.. (2001). Hyaluronic acid as a marker of disease progression in chronic hepatitis. Journal of Hepatology. 34. 166–166. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hany Elsawy Breakdown of academic impact, for papers by Yaqi Zhang Breakdown of academic impact, for papers by Hualei Chen Breakdown of academic impact, for papers by Mahmoud M. A. Elsayed Breakdown of academic impact, for papers by Ming Yuan Breakdown of academic impact, for papers by Mingmei Zhong Breakdown of academic impact, for papers by Bohong Guo Breakdown of academic impact, for papers by Somesh Banerjee Breakdown of academic impact, for papers by Suyavaran Arumugam Breakdown of academic impact, for papers by Subastri Ariraman
Rankless by CCL
2026